David Zeferino D'Azevedo Cristina
Vorstandsvorsitzender bei Acellera Therapeutics Lda.
Aktive Positionen von David Zeferino D'Azevedo Cristina
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Acellera Therapeutics Lda.
 Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Vorstandsvorsitzender | 01.07.2010 | - |
| Gründer | 01.07.2010 | - | |
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Zeferino D'Azevedo Cristina
Ehemalige bekannte Positionen von David Zeferino D'Azevedo Cristina
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Portugal Capital Ventures SCR SA
 Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Berater | 01.03.2015 | 31.10.2017 |
Statistik
International
| Portugal | 4 |
Operativ
| Chief Executive Officer | 1 |
| Founder | 1 |
| Consultant / Advisor | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Health Technology |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Finance |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
